Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Whoa…….

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Feb 14, 2024 7:36am

130 Views

Post# 35879260

RE:Whoa…….

Sweet, just wait until royalty revenues are $15-25M US per year in a couple of years. I actually expected QAPs numbers to be higher, which means Q2 will be extremely strong. Antigens are back and increasing significantly.

Great job team. Hopefully this gets the company and stock some much needed attention.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in